Baldev Singh, MD
Critical Care (Intensivists) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Offices
- 5
Offices
5 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Singh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence C50183 · Current
Licensed to practise in California · since 1999 · expires 2028-04-30 · Fiji Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$77,002
Medicare paid this office $77,002 for 330 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 137 | $45,174 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 138 | $16,569 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $5,940 | $104 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,296 | $104 |
| Test to determine lung volumes using sensors | 45 | $462 | $10 |
See all 7 services
| Critical care, first 30-74 minutes | 137 | $45,174 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 138 | $16,569 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $5,940 | $104 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,296 | $104 |
| Test to determine lung volumes using sensors | 45 | $462 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 51 | $449 | $9 |
| Test to examine how well the lungs exchange gases | 46 | $349 | $8 |
Who their Medicare patients are
330 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 23% · Women 48% · Also on Medicaid 31% · Health risk score 2.53. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Heart failure 53% · Coronary heart disease 50% · Atrial fibrillation 49% · Diabetes 48% · Chronic kidney disease 45% · COPD 36% · Stroke 32% · Dementia 30% · Depression 29% · Cancer 22%.
The office billed $488,125, Medicare allowed $99,304 and paid $77,002; for 774 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 330 | 774 | 77 | 2.53 | $488,125 | $77,002 |
| 2023 | 364 | 1,009 | 78 | 2.25 | $507,061 | $110,028 |
| 2022 | 249 | 854 | 79 | 2.40 | $428,193 | $131,475 |
| 2021 | 271 | 974 | 80 | 1.92 | $273,451 | $141,993 |
| 2020 | 360 | 1,284 | 78 | 2.32 | $355,820 | $189,328 |
| 2019 | 515 | 1,835 | 79 | 2.41 | $467,960 | $243,135 |
| 2018 | 442 | 1,171 | 78 | 2.21 | $311,055 | $179,212 |
| 2017 | 455 | 1,463 | 77 | 2.50 | $427,415 | $284,706 |
| 2016 | 427 | 1,486 | 78 | 2.63 | $459,670 | $227,364 |
| 2015 | 357 | 1,307 | 76 | 2.45 | $420,295 | $212,846 |
| 2014 | 413 | 1,865 | 77 | 2.26 | $579,975 | $294,197 |
| 2013 | 363 | 1,669 | 76 | 2.16 | $516,760 | $253,640 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Critical care, first 30-74 minutes | 176 | $80,654 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 93 | $11,509 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $6,217 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,042 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,753 | $110 |
| Test to determine lung volumes using sensors | 81 | $866 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 91 | $833 | $9 |
| Test to examine how well the lungs exchange gases | 85 | $672 | $8 |
2022: 5 services
| Critical care, first 30-74 minutes | 197 | $102,088 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 98 | $18,481 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,262 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,197 | $65 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 12 | $112 | $9 |
2021: 9 services
| Critical care, first 30-74 minutes | 211 | $102,231 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 140 | $28,598 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,336 | $173 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 16 | $2,117 | $125 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 15 | $1,129 | $75 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $220 | $10 |
| Test to determine lung volumes using sensors | 13 | $156 | $11 |
| Ultrasonic guidance for blood vessel access | 12 | $150 | $13 |
| Test to examine how well the lungs exchange gases | 13 | $116 | $8 |
2020: 10 services
| Critical care, first 30-74 minutes | 252 | $135,837 | $202 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 182 | $36,198 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,564 | $188 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 17 | $2,156 | $127 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 19 | $1,452 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,407 | $67 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 46 | $569 | $12 |
| Test to determine lung volumes using sensors | 21 | $240 | $11 |
| Ultrasonic guidance for blood vessel access | 15 | $197 | $13 |
| Test to examine how well the lungs exchange gases | 23 | $194 | $8 |
2019: 10 services
| Critical care, first 30-74 minutes | 322 | $149,831 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 316 | $66,162 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $12,618 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $3,256 | $65 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 36 | $2,698 | $75 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 14 | $1,723 | $123 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 44 | $521 | $12 |
| Ultrasonic guidance for blood vessel access | 27 | $347 | $13 |
| Test to determine lung volumes using sensors | 23 | $256 | $11 |
| Test to examine how well the lungs exchange gases | 25 | $206 | $8 |
2018: 10 services
| Critical care, first 30-74 minutes | 295 | $132,420 | $220 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 141 | $27,113 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $7,417 | $206 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 20 | $2,014 | $101 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 11 | $1,528 | $139 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 86 | $1,136 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $814 | $74 |
| Test to determine lung volumes using sensors | 41 | $516 | $13 |
| Test to examine how well the lungs exchange gases | 47 | $437 | $9 |
| Ultrasonic guidance for blood vessel access | 15 | $218 | $15 |
2017: 10 services
| Critical care, first 30-74 minutes | 325 | $220,693 | $255 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 175 | $37,982 | $122 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $9,120 | $234 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 28 | $3,781 | $135 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 19 | $3,081 | $154 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 56 | $864 | $15 |
| Insertion of artery tube for blood sampling or infusion through skin | 14 | $818 | $58 |
| Test to determine lung volumes using sensors | 28 | $407 | $15 |
| Test to examine how well the lungs exchange gases | 30 | $322 | $11 |
| Ultrasonic guidance for blood vessel access | 19 | $305 | $16 |
2016: 11 services
| Critical care, first 30-74 minutes | 323 | $178,684 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 170 | $25,267 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,759 | $173 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 32 | $3,435 | $104 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 28 | $2,706 | $93 |
| Manual attempt to restore blood circulation and breathing | 12 | $1,917 | $160 |
| Long return visit (40+ min) | 11 | $1,847 | $132 |
| Ultrasonic guidance for blood vessel access | 29 | $376 | $13 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 27 | $311 | $12 |
| Test to examine how well the lungs exchange gases | 16 | $128 | $8 |
| Test to determine lung volumes using sensors | 11 | $120 | $11 |
2015: 7 services
| Critical care, first 30-74 minutes | 292 | $174,558 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $20,476 | $93 |
| Long return visit (40+ min) | 15 | $3,267 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,076 | $181 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 22 | $2,340 | $106 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 22 | $2,098 | $95 |
| Ultrasonic guidance for blood vessel access | 19 | $246 | $13 |
2014: 14 services
| Critical care, first 30-74 minutes | 313 | $234,541 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 167 | $33,685 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,570 | $176 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 30 | $3,202 | $107 |
| New patient visit (60+ min) | 16 | $2,899 | $181 |
| Long return visit (40+ min) | 14 | $2,524 | $126 |
| Critical care, each additional 30 minutes | 14 | $2,054 | $98 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 20 | $1,910 | $96 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $1,868 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,473 | $61 |
| Ultrasonic guidance for blood vessel access | 28 | $372 | $13 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $258 | $12 |
| Test to determine lung volumes using sensors | 11 | $122 | $11 |
| Test to examine how well the lungs exchange gases | 12 | $98 | $8 |
2013: 11 services
| Critical care, first 30-74 minutes | 267 | $203,274 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 149 | $27,268 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,673 | $173 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 31 | $3,334 | $101 |
| Long return visit (40+ min) | 18 | $2,928 | $117 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $1,948 | $122 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 19 | $1,854 | $93 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 33 | $383 | $12 |
| Ultrasonic guidance for blood vessel access | 25 | $321 | $12 |
| Test to determine lung volumes using sensors | 17 | $198 | $12 |
| Test to examine how well the lungs exchange gases | 18 | $154 | $9 |
Money from drug and device companies
$163 in 2025
| 2025 | 1 | 3 | None | $163 |
| 2022 | 3 | 3 | None | $243 |
| 2021 | 1 | 1 | None | $16 |
| 2020 | 1 | 2 | None | $204 |
| 2019 | 2 | 9 | None | $803 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Penumbra | Indigo System | $163 | 3 payments
|
See all 3 published payments
| Penumbra | Meals · 2025-12-10 | Indigo System | $10 |
| Penumbra | Meals · 2025-12-09 | Indigo System | $30 |
| Penumbra | Meals · 2025-10-28 | Indigo System | $123 |
See earlier years (2022, 2021, 2020, 2019)
2022: $243
| Alexion Pharmaceuticals | Andexxa | $118 | 1 payment
|
| Philips Electronics North America | (6571) Eagle Eye | $90 | 1 payment
|
| Abbott Laboratories | Xience V | $35 | 1 payment
|
2021: $16
| Electromed | Smartvest | $16 | 1 payment
|
2020: $204
| Penumbra | Indigo | $204 | 2 payments
|
2019: $803
| Abbott Laboratories | Xience Sierra Coronary Stent System | $562 | 6 payments
|
| Philips Electronics North America | Igt D Coronary | $241 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1992717953
- Licence
- CA C50183California C50183: Current · expires 2028-04-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00C501830
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 2084A2900X (2084A2900X)
- Mailing address
- 2425 Samaritan Dr, San Jose, CA, 95124
- NPI first listed
- 2006-08-11
- NPI last updated
- 2026-04-08
- NPI record certified
- 2026-04-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: Po Box 742244, Los Angeles, CA, 90074 · 815 Pollard Rd, Los Gatos, CA, 95032